What is the recommended dosage of cefuroxime (Cefuroxime) IV for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Cefuroxime IV Dosing Recommendations

The recommended intravenous (IV) dosage of cefuroxime for pediatric patients is 100-200 mg/kg/day divided every 6-8 hours, with a maximum dose of 1500 mg per dose. 1

Dosing Guidelines by Age and Indication

Neonates and Infants

  • For neonates less than 7 days old: 30 mg/kg IV every 12 hours 1
  • For neonates greater than 7 days old: 30 mg/kg IV every 8 hours 1
  • For infants over 1 month: 100-150 mg/kg/day divided every 6-8 hours 1

Children

  • For most pediatric infections: 100-150 mg/kg/day divided every 6-8 hours 1, 2
  • For severe infections: 150-200 mg/kg/day divided every 6-8 hours 1, 2
  • Maximum daily dose should not exceed 6000 mg per day (1500 mg per dose) 1

Indication-Specific Dosing

Respiratory Tract Infections

  • For pneumonia and other respiratory infections: 100-150 mg/kg/day divided every 8 hours 1, 3
  • Some studies have shown efficacy with 75 mg/kg/day divided every 8 hours for pneumonia 3

Soft Tissue Infections

  • For soft tissue infections: 75-100 mg/kg/day divided every 8 hours 4
  • For severe infections: increase to 150-200 mg/kg/day 1

Intra-abdominal Infections

  • For complicated intra-abdominal infections: 150 mg/kg/day divided every 6-8 hours 1

Meningitis and Severe Infections

  • For bacterial meningitis: 200-240 mg/kg/day divided every 6-8 hours is recommended (though third-generation cephalosporins are generally preferred) 1, 2

Administration Considerations

  • For direct intermittent IV administration, slowly inject the solution over 3-5 minutes 2
  • For intermittent IV infusion, cefuroxime can be administered through Y-type administration sets 2
  • Duration of therapy should be based on clinical response, typically 5-10 days for most infections 2

Dosage Adjustments

  • For patients with renal impairment, dosage adjustment is necessary 2:
    • Creatinine clearance >20 mL/min: standard dosing
    • Creatinine clearance 10-20 mL/min: 75% of standard dose every 12 hours
    • Creatinine clearance <10 mL/min: 50% of standard dose every 24 hours

Clinical Pearls and Caveats

  • Cefuroxime has good activity against common pediatric pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and methicillin-sensitive Staphylococcus aureus 5, 3
  • For suspected MRSA infections, additional coverage with vancomycin or clindamycin is recommended 1
  • Therapeutic drug monitoring is not routinely required for cefuroxime 2
  • For patients with beta-lactam allergies, alternative agents should be considered based on the severity of the allergy 1
  • Studies have shown that cefuroxime achieves adequate concentrations in pleural fluid, making it suitable for respiratory infections 3

Oral Step-Down Therapy

  • When switching to oral therapy, cefuroxime axetil can be used at a dose of 20-50 mg/kg/day divided every 12 hours (maximum 500 mg per dose) 1, 5
  • Oral bioavailability is improved when administered with food 5

Remember that while these dosing recommendations are evidence-based, clinical judgment should be exercised based on the severity of infection, local antimicrobial resistance patterns, and patient-specific factors.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cefuroxime therapy for pneumonia in infants and children.

Pediatric infectious disease, 1982

Research

Cefuroxime therapy for bacteremic soft-tissue infections in children.

American journal of diseases of children (1960), 1985

Research

Cefuroxime axetil.

International journal of antimicrobial agents, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.